High-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoprotein
about
Pharmacological inhibition of feline immunodeficiency virus (FIV)Recent advances in engineering polyvalent biological interactionsDeveloping the IVIG biomimetic, hexa-Fc, for drug and vaccine applicationsSynthesis, characterization and fluorescent properties of water-soluble glycopolymer bearing curcumin pendant residues.Selection of a synthetic glycan oligomer from a library of DNA-templated fragments against DC-SIGN and inhibition of HIV gp120 binding to dendritic cells.Structural characterization of the DC-SIGN-Lewis(X) complexGlycosaminoglycans are interactants of Langerin: comparison with gp120 highlights an unexpected calcium-independent binding modeA Detailed Study on Understanding Glycopolymer Library and Con A InteractionsCarbohydrate-Based Polymers for Immune ModulationQuinoxalinone Inhibitors of the Lectin DC-SIGN.Noncarbohydrate glycomimetics and glycoprotein surrogates as DC-SIGN antagonists and agonists.Glycopolymer probes of signal transductionLinear biocompatible glyco-polyamidoamines as dual action mode virus infection inhibitors with potential as broad-spectrum microbicides for sexually transmitted diseases"Clicking" on/with polymers: a rapidly expanding field for the straightforward preparation of novel macromolecular architectures.Multivalency in heterogeneous glycoenvironments: hetero-glycoclusters, -glycopolymers and -glycoassemblies.Glycopolymers and glyco-nanoparticles in biomolecular recognition processes and vaccine development.Bitter-sweet symphony: glycan-lectin interactions in virus biology.Therapeutic potential of carbohydrate-based polymeric and nanoparticle systems.Polymeric anti-HIV therapeutics.Glycopolymer code based on well-defined glycopolymers or glyconanomaterials and their biomolecular recognition.Identification of Multiple Druggable Secondary Sites by Fragment Screening against DC-SIGN.Nanoscale materials for probing the biological functions of the glycocalyx.Sugared biomaterial binding lectins: achievements and perspectives.Designing nanomolar antagonists of DC-SIGN-mediated HIV infection: ligand presentation using molecular rods.Polyvalent display of monosaccharides on ferritin protein cage nanoparticles for the recognition and binding of cell-surface lectins.Preparation, cellular internalization, and biocompatibility of highly fluorescent PMMA nanoparticles.Polymeric mannosides prevent DC-SIGN-mediated cell-infection by cytomegalovirus.Glycan heterogeneity on gold nanoparticles increases lectin discrimination capacity in label-free multiplexed bioassays.Polymerization-induced self-assembly of galactose-functionalized biocompatible diblock copolymers for intracellular deliveryPoly-amido-saccharides: synthesis via anionic polymerization of a β-lactam sugar monomer.Synthetic glycopolypeptides as potential inhibitory agents for dendritic cells and HIV-1 trafficking.Synthesis of homo- and heteromultivalent carbohydrate-functionalized oligo(amidoamines) using novel glyco-building blocks.Sequence-controlled multi-block glycopolymers to inhibit DC-SIGN-gp120 binding.Manipulation of cytokine secretion in human dendritic cells using glycopolymers with picomolar affinity for DC-SIGN.Synthesis of LewisX-O-Core-1 threonine: A building block for O-linked LewisX glycopeptides.Split-and-Combine Approach Towards Branched Precision Glycomacromolecules and Their Lectin Binding Behavior.Glycopolymeric Materials for Advanced Applications.Triggerable Multivalent Glyconanoparticles for Probing Carbohydrate-Carbohydrate Interactions.Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cellsThe Glycopolymer Code: Synthesis of Glycopolymers and Multivalent Carbohydrate-Lectin Interactions
P2860
Q26995310-A887B6B2-6FFB-4AAF-AF70-0AF719D04B09Q27011503-397C5555-67BE-430A-86CC-A0E716B5E696Q30834514-92CB3BC1-BF66-40A8-98DD-6CE87805F7BEQ31081880-E9DC79E9-9357-4FC9-8238-6F88F9F97176Q33970022-3A373110-9B97-431D-B792-797FC7E012D1Q34155606-A52FDA19-AAF5-4104-B655-BF9BFC0BFEA2Q34505798-0072118F-DCF0-4A7B-BCF7-65B34E87BE3CQ34769228-CA1816CA-FC80-4CA3-A2B4-16779AD9882BQ35212993-CF462B70-372B-4124-9B31-84A62B3FB508Q35983604-FF09A140-75B9-4868-9AE3-4F7048D2A2EBQ36431101-D758E508-CF75-4890-828A-5471B9206EF4Q37257032-A8DA02CC-9C81-4432-B945-DA22EAC5564FQ37264587-CBA9F4BF-5152-4B6A-9BCB-AD43EB8449ECQ37897142-3BF80E92-9A9B-4FCF-82C0-AAB5C94100E3Q38036582-70161CCF-CD0E-4ABD-AD2F-CD619CD12FC2Q38050110-44990770-BAB7-4067-9F43-1D9E3461EE89Q38159719-D0BC6D47-3F6B-43EE-9C08-AA7726F61C73Q38199152-3E842242-CD4C-4746-A983-C800EB7365F2Q38245819-ABABADE6-9A7D-4DBC-B7BA-BF6CC1B89EDDQ38263537-4F9AEE80-E35A-40A3-9A08-12148B007C63Q38681868-A0DFE226-E6B8-4BDB-9D89-A29A7731A4ADQ38750826-E3B4EC3E-6CC4-4DF4-B6DD-338CFB67C1C3Q38807532-CCBDDC07-19CB-4F1E-8AD4-6528B1BCA295Q38913283-382F68A3-8E06-4576-8825-DF4B97F39B0BQ39025143-EAF4E19F-6E46-433B-B25F-906A69EF659BQ39298740-4CD1674D-BBDB-4ACB-8280-A6819241F8BDQ40058137-52F0AA54-0389-4139-BB40-43045C1DD422Q40673980-49218608-CDC4-4E06-AE48-1EA251F60766Q42120198-C62C2443-2AC6-43D1-8643-90A2FB7905A5Q42158217-C3AA0A0C-6279-4640-BF36-A21AF3C612D4Q42269303-DEB4A1F1-DC75-45E8-A29C-50B6BE72168BQ42782363-299EE57F-7D2F-4130-BFFC-9D5D5B507D54Q44555796-3BA0827E-7064-4548-A760-1101E059D319Q47133587-941DA4D7-8511-4B50-881B-6E256AFAAE9BQ47415509-73A04DE1-8470-4F7B-A412-16CB691D9940Q48362759-5D30846A-E3F2-4A63-A0CD-DD7B4E08C157Q50295952-AC1E0D62-7A17-4EA7-8C77-FC8E1C9F41FAQ55299943-AF70B7F6-47B2-4315-8A98-D1472C2081DCQ57261966-95B0B479-A04E-4C70-A027-F981F6101AADQ57350433-2968E330-DA89-45AF-AF41-9B83337706CC
P2860
High-affinity glycopolymer binding to human DC-SIGN and disruption of DC-SIGN interactions with HIV envelope glycoprotein
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
High-affinity glycopolymer bin ...... with HIV envelope glycoprotein
@ast
High-affinity glycopolymer bin ...... with HIV envelope glycoprotein
@en
High-affinity glycopolymer bin ...... with HIV envelope glycoprotein
@nl
type
label
High-affinity glycopolymer bin ...... with HIV envelope glycoprotein
@ast
High-affinity glycopolymer bin ...... with HIV envelope glycoprotein
@en
High-affinity glycopolymer bin ...... with HIV envelope glycoprotein
@nl
prefLabel
High-affinity glycopolymer bin ...... with HIV envelope glycoprotein
@ast
High-affinity glycopolymer bin ...... with HIV envelope glycoprotein
@en
High-affinity glycopolymer bin ...... with HIV envelope glycoprotein
@nl
P2860
P50
P3181
P356
P1476
High-affinity glycopolymer bin ...... with HIV envelope glycoprotein
@en
P2093
Rebecca Ilyas
P2860
P304
15130-15132
P3181
P356
10.1021/JA1056714
P407
P577
2010-11-01T00:00:00Z